3/24/2026 1:47:23 PM Competition authorities in Europe target ‘killer acquisitions’ – what biotech companies need to know By Sophie Lawrance Victoria Yuan This article is part of our Biotech Review of the Year - Issue 13 publication. Competition authorities are increasingly targeting...
3/24/2026 1:47:20 PM Budget 2025: the key tax measures supporting science and innovation By Julia Cockroft Tabitha Reed This article is part of our Biotech Review of the Year - Issue 13 publication. On 26 November 2025, Rachel Reeves delivered her...
3/24/2026 1:47:17 PM Top 10 corporate, tax and employment considerations for early-stage and spin-out biotech companies By Samuel Munday Manon Rattle Tabitha Reed This article is part of our Biotech Review of the Year - Issue 13 publication. Launching and scaling a biotech company offers immense...
3/24/2026 1:47:13 PM Half the population, half the data: addressing the women’s health gap in clinical research By Ellie Handy Laura Harwood Soraya Gajra This article is part of our Biotech Review of the Year - Issue 13 publication. Historically, women have been underrepresented in clinical...
3/24/2026 1:47:10 PM Cell and gene therapy: all aboard the rollercoaster ride... By Claire Smith Adam Coughlin Gabriela Swiderska This article is part of our Biotech Review of the Year - Issue 13 publication. Over the last few years, arguably no other part of the...